Neisseria gonorrhoeae

What the laboratory says this test is for

Neisseria gonorrhoeae is considered a pathogen whenever isolated and its identification is important in initiating appropriate therapy to prevent the spread of the infection as well as the serious sequelae.

What the laboratory says this test is for

To screen for the infection with Neisseria gonorrhoeae and Chlamydia trachomatis in vaginal, endocervical and urethral swabs or urine from men and women.

What the laboratory says this test is for

This new test code is designed to help clinicians order age-appropriate testing for cervical cancer screening and STIs. Based on the patient's age and on ACOG Practice Guidelines for cervical cancer screening and Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) screening, testing in addition to the Pap will be processed as follows: • Patients aged 21-24: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. Additionally, testing for CT/NG will be performed. • Patients aged 25-29: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. • Patients aged 30-65: Patients will receive Image-guided Pap and a high-risk HPV mRNA test. When the Pap result is negative but the HPV mRNA screen is positive, Genotyping for HPV mRNA 16, 18/45 will be performed. • Patients falling outside of the above age ranges, or without a date of birth, will receive an Image-guided Pap only. Codes may include ThinPrep® or SurePath™ Image-guided Paps, HPV mRNA, CT/NG.

What the laboratory says this test is for

This new test code will perform like test code 91384 but will always add Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis ("trich" or TV) testing to the Pap. Specifically, testing will occur as follows: • Patients aged 21-24: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. Additionally, CT/NG and TV will be performed. • Patients aged 25-29: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. Additionally, CT/NG and TV will be performed. • Patients aged 30-65: Patients will receive Image-guided Pap and a high-risk HPV mRNA test. When the Pap result is negative but the HPV mRNA screen is positive, Genotyping for HPV mRNA 16, 18/45 will be performed. Additionally, CT/NG and TV will be performed. • Patients falling outside of the above age ranges, or without a date of birth, will receive an Image-guided Pap. Additionally, CT/NG and TV will be performed. Codes may include ThinPrep® or SurePath™ Image-guided Paps, HPV mRNA, CT/NG/TV.

What the laboratory says this test is for

This new test code will perform like test code 91384 but will always add Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing to the Pap. Specifically, testing will occur as follows: • Patients aged 21-24: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. Additionally, testing for CT/NG will be performed. • Patients aged 25-29: Patients will receive Image-guided Pap and, when the result is ASC-US, a high-risk HPV mRNA test will be performed. Additionally, testing for CT/NG will be performed. • Patients aged 30-65: Patients will receive Image-guided Pap and a high-risk HPV mRNA test. When the Pap result is negative but the HPV mRNA screen is positive, Genotyping for HPV mRNA 16, 18/45 will be performed. Additionally, testing for CT/NG will be performed. • Patients falling outside of the above age ranges, or without a date of birth, will receive an Image-guided Pap and additionally, testing for CT/NG will be performed. Codes may include ThinPrep® or SurePath™ Image-guided Paps, HPV mRNA, CT/NG.

What the laboratory says this test is for

C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydial infections are severe if left untreated. Approximately half of Chlamydial infections are asymptomatic.⁠⁠⁠⁠⁠⁠⁠Neisseria gonorrhoeae (gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected.